Celldex Therapeutics | CLDX - Ebitda





Ebitda Alterar Data
AbbVie USD 6.91B 3.22B 2026-06
Agenus USD -10.11M 19.02M 2025-03
Amgen USD 5.8B 1.25B 2026-09
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Celldex Therapeutics USD -79.72M 3.86M 2026-06
Glaxosmithkline GBP 2.93B 154M 2026-09
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Northwest Biotherapeutics USD -13.41M 232K 2023-09
Pfizer USD 6.36B 350M 2026-09
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Roche Holding CHF 13.43B 744M 2026-06